ULTRALIFE CORP (ULBI) - Form 8-K Summary
Business Context and Reporting Period
Ultralife Corporation, a Delaware corporation, filed this Current Report on Form 8-K on July 25, 2024. The filing serves to announce the financial results for the second quarter ended June 30, 2024, via a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the referenced press release (Exhibit 99.1) which is incorporated by reference but not included in the source text provided.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative financial analysis.
Guidance, Outlook, and Risks
This 8-K filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. Such information is expected to be found within the full text of the press release referenced in Item 2.02.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2024 revenue and net income figures.
- Verify year-over-year and quarter-over-quarter growth rates in the attached press release.
- Check for any updated full-year guidance or outlook statements in the press release.
- Confirm the absence of any material legal proceedings or debt covenant issues in the full disclosure.